Vitamin D deficiency and osteoporosis: The role of vitamin D deficiency and treatment with vitamin D and analogues in the prevention of osteoporosis-related fractures

European Journal of Clinical Investigation

Volumn 26, Issue 6, 1996, Pages 436-442

  Lips, P ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALFACALCIDOL; CALCITRIOL; VITAMIN D; VITAMIN D DERIVATIVE;

AGING; BONE ATROPHY; FEMALE; HIP FRACTURE; HUMAN; OSTEOPOROSIS; PRIORITY JOURNAL; REVIEW; VITAMIN D DEFICIENCY;

EID: 0030009809     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.1996.176290.x     Document Type: Review

References (50)

1. Chalmers J, Conacher WDH, Gardner DL, Scott PJ. Osteomalacia, a common disease in elderly women. J Bone Joint Surg 1967;49B:403-23.
2. Lips P, Obrant K. The pathogenesis and treatment of hip fractures. Osteoporosis Int 1991;I:218-31.
3. Gallagher JC, Riggs BL, Eisman J, Hamstra A, Arnaud SB, DeLuca HF. Intestinal calcium absorption and serum vitamin D metabolites in normal subjects and osteoporotic patients. J Clin Invest 1979;64:729-36.
4. Holick MF. Vitamin D and the skin: photobiology, physiology and therapeutic efficacy for psoriasis. In: Heersche JNM, Kanis JA, eds. Bone and Mineral Research. Elsevier, Amsterdam 1990; 7:313-66.
5. McKenna M. Differences in vitamin D status between countries in young adults and the elderly. Am J Med 1992;93:69-77.
6. Lips P, van Ginkel FC, Jongen MJM, Rubertus A, van der Vijgh WJF, Netelenbos JC. Determinants of vitamin D status in patients with hip fracture and elderly control subjects. Am J Clin Nutr 1987;46:1005-10.
7. DeLuca HF. Osteoporosis and the metabolites of vitamin D. Metabolism 1990;39:S1:3.
8. Netelenbos JC, Jongen MJM, van der Vijgh WJF, Lips P, van Ginkel FC. Vitamin D status in urinary calcium stone formation. Arch Intern Med 1985;145:681-5.
9. Lips P, Wiersinga A, van Ginkel FC et al. The effect of vitamin D supplementation on vitamin D status and parathyroid function in elderly subjects. J Clin Endocrinol Metab 1988;67: 644-50.
10. Ooms ME. Osteoporosis in elderly women: vitamin D deficiency and other risk factors. PhD Thesis Vrije Universiteit Amsterdam, 1994.
11. Skinner RK, Long RG, Sherlock S, Wills MR. 25-Hydroxylation of vitamin D in primary biliary cirrhosis. Lancet 1977;1:720-1.
12. Juttman JR, Buurman CJ, de Kam E, Visser TJ, Birkenhäger JC. Serum concentrations of metabolites of vitamin D in patients with chronic renal failure. Clin Endocrinol 1981;14: 225-36.
13. Sherman SS, Hollis BW, Tobin J. Vitamin D status and related parameters in a healthy population: the effects of age, sex and season. J Clin Endocrinol Metab 1990;71:405-13.
14. Elders PJM, Netelenbos JC, Lips P et al. Calcium supplementation reduces vertebral bone loss in perimenopausal women: a controlled trial in 248 women between 46 and 55 years of age. J Clin Endocrinol Metab 1991;73:533-40.
15. Lips P, Netelenbos JC, Jongen MJM et al. Histomorphometric profile and vitamin D status in patients with femoral neck fracture. Metab Bone Dis Rel Res 1982;4:85-93.
16. Bouillon RA, Auwerx JH, Lissens WD, Pelemans WK. Vitamin D status in the elderly; seasonal substrate deficiency causes 1,25-dihydroxycholecalciferol deficiency. Am J Clin Nutr 1987;45: 755-63.
17. Khaw KT, Sneyd MJ, Compston J. Bone density, parathyroid hormone and 25-hydroxyvitamin D concentrations in middle-aged women. Br Med J 1992;305:273-7.
18. Ooms ME, Lips P, Roos JC et al. Vitamin D status and sex hormone binding globulin: determinants of bone turnover and bone mineral density in elderly women. J Bone Mineral Res 1995;10:1177-84.
19. Lips P, Hackeng WHL, Jungen MJM, van Ginkel FC, Netelenbos JC. Seasonal variation in serum concentrations of parathyroid hormone in elderly people. J Clin Endocrinol Metab 1983;57:204-6.
20. Von Knorring J, Slätis T, Weber TH, Helenius T. Serum levels of 25-hydroxyvitamin D, 24,25-dihydroxyvitamin D and parathyroid hormone in patients with femoral neck fracture in Southern Finland. Clin Endocrinol 1982;17:189.
21. Parfitt AM. Morphologic basis of bone mineral measurements: transient and steady state effects of treatment in osteoporosis. Mineral Electrolyte Metab 1980;4:273-87.
22. Parfitt AM, Gallagher JC, Heaney RP, Johnston CC, Neer R and Whedon GD. Vitamin D and bone health in the elderly. Am J Clin Nutr 1982;36:1014-1031.
23. Silverberg SJ, Shane E, de la Cruz L et al. Skeletal disease in primary hyperparathyroidism. J Bone Mineral Res 1989;4:283-91.
24. Frame B, Parfitt AM. Osteomalacia: current concepts. Ann Intern Med 1978;89:966-82.
25. Aaron JE, Gallagher JC, Anderson J et al. Frequency of osteomalacia and osteoporosis in fractures of the proximal femur. Lancet 1974;1:229-33.
26. Hordon LD, Peacock M. Osteomalacia and Osteoporosis in femoral neck fracture. Bone Mineral 1990;11:247-59.
27. Parfitt AM, Rao DS, Stanciu J, Villanueva AR, Kleerekoper M, Frame B. Irreversible bone loss in osteomalacia: comparison of radial photon absorptiometry with iliac bone histomorphometry during treatment. J Clin Invest 1985;76:2403-12.
28. Heaney RP, Recker RR, Stegeman MR, Moy AJ. Calcium absorption in women: relationships to calcium intake, estrogen status and age. J Bone Mineral Res 1989;4:469-75.
29. Krall EA, Sahyoun N, Tannenbaum S, Dallal GE, Dawson-Hughes B. Effect of vitamin D intake on seasonal variations in parathyroid secretion in postmenopausal women. N Eng J Med 1989;321:1777-83.
30. 2D. Am J Clin Nutr 1990;52:701-6.
31. Davies M, Mawer EB, Hann JT, Stephens WP, Taylor JL. Vitamin D prophylaxis in the elderly: a simple, effective method suitable for large populations. Age Ageing 1985;14:349-54.
32. Khaw KT, Scragg R, Murphy S. Single-dose cholecalciferol suppresses the winter increase in parathyroid hormone concentrations in healthy older men and women. Am J Clin Nutr 1994; 59:1040-4.
33. Nordin BEC, Baker MR, Horsman A, Peacock M. A prospective trial on the effect of vitamin D supplementation on metacarpal bone loss in elderly women. Am J Clin Nutr 1985;42: 470-4.
34. Dawson-Hughes B, Dallal GE, Krall EA, Harris S, Sokoll LJ, Falconer G. Effect of vitamin D supplementation on wintertime and overall bone loss in healthy postmenopausal women. Ann Intern Med 1991;115:505-12.
35. Heikinheimo RJ, Inkovaara JA, Harju EJ et al. Annual injection of vitamin D and fractures of aged bones. Calcif Tissue Int 1992;51:105-10.
36. Ooms ME, Roos JC, Bezemer PD et al. Prevention of bone loss by vitamin D supplementation in elderly women: a randomized double-blind trial. J Clin Endocrinol Metab 1995;80:1052-8.
37. Dawson-Hughes B, Harris SS, Krall EA, Dallal GE, Falconer G, Green CL. Rates of bone loss in postmenopausal women randomly assigned to one of two dosages of vitamin D. Am J Clin Nutr 1995;61:1140-5.
38. Chapuy MC, Arlot ME, Duboeuf F et al. Vitamin D3 and calcium to prevent hip fractures in elderly women. N Engl J Med 1992;327:1637-42.
39. Chapuy MC, Arlot ME, Delmas PD, Meunier PJ. Effect of calcium and cholecalciferol treatment for three years on hip fractures in elderly women. Br Med J 1994;308:1081-2.
40. Lips P, Graafmans WC, Ooms ME, Bezemer PD, Bouter LM. The effect of vitamin D supplementation on the incidence of hip fractures in elderly people. J Bone Mineral Res 1994;9:S148 (abstract).
41. Eastell R, Yergey AL, Vieira NE, Cedel SL, Kumar R, Riggs BL. Interrelationship among vitamin D metabolism, true calcium absorption, parathyroid function and age in women: evidence of an age-related intestinal resistance to 1.25-dihydroxy-vitamin D action. J Bone Mineral Res 1941;6:125-32.
42. Need AG, Horowitz M, Philcox JC, Nordin BEC. 1,25-dihydroxycalciferol and calcium therapy in osteoporosis with calcium malabsorption. Mineral Electrolyte Metab 1983;11:35-40.
43. Falch JA, Odegaard OR, Finnanger AM, Matheson I. Postmenopausal osteoporosis: no effect of three years treatment with 1,25-dihydroxycholecalciferol. Acta Med Scand 1987;221:199-204.
44. 3. Bone Mineral 1987;3:47-52.
45. Aloia JF, Vaswani A, Yeh JK, Ellis K, Yasamura S, Cohn SH. Calcitriol in the treatment of postmenopausal osteoporosis. Am J Med 1988;84:401-8.
46. Ott SM, Chesnut CH. Calcitriol treatment is not effective in postmenopausal osteoporosis. Ann Intern Med 1989;110:267-74.
47. Gallagher JC, Goldgar D. Treatment of postmenopausal osteoporosis with high doses of synthetic calcitriol. Ann Intern Med 1990;113:649-55.
48. Tilyard M, Spears GFS, Thomson J, Dovey S. Treatment of postmenopausal osteoporosis with calcitriol or calcium. N Engl J Med 1992;326:357-62.
49. Braun JJ, Birkenhäger-Frenkel DH, Rietveld AH, Juttmann JR, Visser TJ, Birkenhäger JC. Influence of 1 α-(OH)D3 administration on bone and bone mineral metabolism in patients on chronic glucocorticoid treatment: a double-blind controlled study. Clin Endocrinol 1983;18:265-73.
50. Sambrook P, Birmingham J, Kelly P et al. Prevention of corticosteroid osteoporosis: a comparison of calcium, calcitriol and calcitonin. N Engl J Med 1993;328:1747-1752.